Comparison of pentoxifylline, thalidomide and prednisone in the treatment of ENL.
Moreira
A L
AL
Kaplan
G
G
Villahermosa
L G
LG
Fajardo
T J
TJ
Abalos
R M
RM
Cellona
R V
RV
Balagon
M V
MV
Tan
E V
EV
Walsh
G P
GP
D000293:Adolescent; D000328:Adult; D016207:Cytokines / Q000097:blood; D004893:Erythema Nodosum / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015440:Leprosy, Lepromatous / Q000097:blood / Q000188:drug therapy*; D008297:Male; D010431:Pentoxifylline / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D018121:Receptors, Cytokine / Q000097:blood; D013792:Thalidomide / Q000627:therapeutic use*
D016207:Cytokines; D018121:Receptors, Cytokine; D013792:Thalidomide; D010431:Pentoxifylline; D011241:Prednisone